Cassava Sciences Inc.

NASDAQ: SAVA · Real-Time Price · USD
2.35
-0.06 (-2.49%)
At close: Aug 15, 2025, 3:59 PM
2.33
-0.85%
After-hours: Aug 15, 2025, 07:46 PM EDT

Cassava Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a 2.35M n/a n/a n/a -1.8K n/a n/a n/a -200 n/a n/a n/a
Cost of Revenue
n/a n/a n/a 300K 311K 356K 392K 391K 391K 389K 300K 299K 313K 313K 212K 8K 1K
Gross Profit
n/a n/a n/a -300K -311K 1.99M -392K -391K -391K -390.8K -300K -299K -313K -313.2K -212K -8K -1K
Operating Income
-24.59M -29.49M -30.62M -67.2M -19.93M -22.79M -27.88M -28.78M -26.9M -20.94M -21.34M -19.92M -17.82M -14.44M -9.75M -5.14M -3.53M
Interest Income
1.26M 1.8M 2.62M 2.32M 1.78M 1.58M 2M 2.2M 2.05M 1.55M 878K 314K 31K 14K 15K 13K 7K
Pretax Income
-23.4M -27.6M -27.94M 6.16M 25.04M -20.92M -25.65M -26.38M -24.27M -19.13M -20.26M -19.33M -17.53M -14.17M -9.56M -5.13M -3.53M
Net Income
-23.4M -27.6M -27.94M 6.16M 25.04M -20.92M -25.65M -26.38M -21.64M -17.33M -19.17M -18.43M -17.23M -14.17M -9.56M -5.13M -3.53M
Selling & General & Admin
10.92M 8.96M 12.95M 51.7M 3.39M 3.7M 4.28M 3.81M 4.39M 3.29M 2.82M 2.97M 2.92M 4.1M 1.71M 1.24M 1M
Research & Development
13.67M 20.53M 17.68M 15.2M 16.23M 18.73M 23.6M 24.97M 22.12M 17.65M 18.53M 16.95M 14.91M 10.34M 8.04M 3.9M 2.53M
Other Expenses
n/a n/a n/a 99K 160K n/a 223K 203K 190K 249K 210K 275K 263K 258K 176K n/a n/a
Operating Expenses
24.59M 29.23M 30.62M 66.9M 19.62M 22.43M 27.88M 28.78M 26.51M 20.94M 21.34M 19.92M 17.82M 14.44M 9.75M 5.14M 3.53M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a 5.5M -311K -356K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
24.59M 24.91M 30.62M 67.2M 19.93M 22.79M 27.88M 28.78M 26.51M 20.94M 21.34M 19.92M 17.82M 14.44M 9.75M 5.14M 3.53M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a -2.63M -1.8M -1.09M -903K -294K n/a n/a -13K -7K
Shares Outstanding (Basic)
48.26M 48.1M 47.98M 46.2M 43M 42.19M 42M 41.79M 41.74M 40.77M 40.05M 40.02M 39.96M 39.96M 39.96M 39.95M 37.72M
Shares Outstanding (Diluted)
48.26M 48.1M 47.98M 46.2M 44.1M 42.19M 42M 41.79M 41.74M 40.77M 40.05M 40.02M 39.96M 39.96M 39.96M 39.95M 37.72M
EPS (Basic)
-0.48 -0.6 -0.58 0.13 0.58 -0.5 -0.61 -0.63 -0.52 -0.43 -0.48 -0.46 -0.43 -0.35 -0.24 -0.13 -0.09
EPS (Diluted)
-0.48 -0.59 -0.58 0.13 -0.43 -0.5 -0.61 -0.63 -0.52 -0.43 -0.48 -0.46 -0.43 -0.35 -0.24 -0.13 -0.09
EBITDA
-24.37M -28.73M -31.46M -61.09M -19.62M -22.43M -27.49M -28.39M -26.12M -20.55M -21.05M -19.62M -17.51M -14.13M -9.54M -5.13M -3.53M
EBIT
-24.59M -27.6M -30.62M -61.4M -19.93M -22.79M -27.88M -28.78M -26.51M -20.94M -21.34M -19.92M -17.82M -14.44M -9.75M -5.14M -3.53M
Depreciation & Amortization
n/a 260K 259K 300K 311K 356K 392K 391K 391K 389K 300K 299K 313K 313K 212K 8K 1K